REQUEST A DEMO
Total
USD $0.00
Search more companies

Latvijas Aptieka SIA (Latvia)

Main Activities: Pharmacies and Drug Stores
Full name: Latvijas Aptieka SIA Profile Updated: December 24, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

Latvijas Aptieka SIA is a pharmaceutical retail company. It specializes in the care of special groups of patients and rare diseases, offering a range of medical goods, natural anti-virus drugs, and pharmaceutical care products. The company also provides services such as breast cancer screening with 3D tomosynthesis and vena treatment technologies. With more than 20 branches and a network of associated companies, Latvijas Aptieka SIA is recognized for its customer service in the pharmaceutical sector.

Headquarters
Krisjana Valdemara iela 70
Riga; Riga; Postal Code: 1013

Contact Details: Purchase the Latvijas Aptieka SIA report to view the information.

Website: http://www.latvijasaptiekas.lv

Basic Information
Total Employees:
Purchase the Latvijas Aptieka SIA report to view the information.
Registered Capital:
Purchase the Latvijas Aptieka SIA report to view the information.
Financial Auditors:
Purchase the Latvijas Aptieka SIA report to view the information.
Incorporation Date:
October 05, 1992
Key Executives
Purchase this report to view the information.
Chairman of the Supervisory Board
Purchase this report to view the information.
Member of Management Board
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Latvijas Aptieka SIA report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
5.29%
Total operating revenue
5.47%
Operating profit (EBIT)
1.67%
EBITDA
1.67%
Net Profit (Loss) for the Period
17.86%
Total Assets
18.15%
Total Equity
25.62%
Operating Profit Margin (ROS)
-0.18%
Net Profit Margin
0.59%
Return on Equity (ROE)
-1.35%
Quick Ratio
0.21%
Cash Ratio
0.19%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?